Hostname: page-component-8448b6f56d-cfpbc Total loading time: 0 Render date: 2024-04-18T18:58:01.663Z Has data issue: false hasContentIssue false
  • English
  • Français

Antipsychotic polypharmacy and early death

Published online by Cambridge University Press:  02 January 2018

R. P. Smith
R. P. Smith*
Affiliation:
University of Leeds School of Medicine, Division of Psychiatry and Behavioural Sciences in Relation to Medicine, Level 5, Clinical Sciences Building, St James's University Hospital, Leeds LS9 7TF
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 174 , Issue 4 , April 1999 , pp. 368
Copyright
Copyright © 1999 The Royal College of Psychiatrists 

References

Andrews, P., Hall, J. N. & Snaith, R. P. (1976) A controlled trial of phenothiazine withdrawal in chronic schizophrenic patients. British Journal of Psychiatry, 128, 451–455.Google Scholar
Waddington, J. L., Youssef, H. A. & Kinsella, A. (1998) Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study. British Journal of Psychiatry, 173, 325–329.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.